Logo Dr. Emily S. Tonorezos, director of NCI's Office of Cancer Survivorship, offers a word of encouragement and support for Nati ...

Short interest in SpringWorks Therapeutics Inc (NASDAQ:SWTX) increased during the last reporting period, rising from 7.11M to 7.53M. This put 12.14% of the company's publicly available shares short.

A development deal with Biogen Inc. could eventually bring City Therapeutics Inc. about $1 billion in milestone payments. Privately held City Therapeutics is getting $46 million in the deal. That ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” first quarter ...

As soon as the news broke of a major layoff at New Haven biopharma company Arvinas earlier this month, texts and emails were flying across Connecticut between pharma executives, industry boosters and ...

EMA committee recommends marketing approval for SpringWorks’ mirdametinib to treat adult & paediatric patients with NF1-PN: Stamford, Connecticut Tuesday, May 27, 2025, 12:00 Hr ...

SpringWorks Therapeutics SWTX announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion recommending conditional ...